BioCatalystWatch
KZIAWorkspace / KZIA / OverviewCompany library
KAZIA THERAPEUTICS LTD logo

KAZIA THERAPEUTICS LTD

KAZIA THERAPEUTICS LTD (KZIA)

Website

Price
Market cap
Next catalystDec 8-11, 2026Paxalisib · Conference presentationCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

Paxalisib

PI3K × mTOR

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Paxalisib

PI3K × mTOR

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Paxalisib

PI3K × mTOR

PreINDP1P2P3FilingApproved
Paxalisib

PI3K × mTOR

PreINDP1P2P3FilingApproved
Paxalisib

PI3K × mTOR

PreINDP2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Paxalisib

PI3K × mTOR

PreINDP1P3FilingApproved
Upcoming / outlook

  • Timing and evidence

NDL2

PD-L1

PreINDP1P2P3FilingApproved
MSETC

SETDB1

PreINDP1P2P3FilingApproved

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

Paxalisib

PI3K × mTOR

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Paxalisib

PI3K × mTOR

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Paxalisib

PI3K × mTOR

PreINDP2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Paxalisib

PI3K × mTOR

PreINDP1P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Other pipelines

Paxalisib

PI3K × mTOR

PreINDP1P2P3FilingApproved
Paxalisib

PI3K × mTOR

PreINDP1P2P3FilingApproved
EVT801

VEGFR3

PreINDP1P2P3FilingApproved
EVT801

VEGFR3

Partner / License out

Paxalisib

PI3K × mTOR

PreINDP1P2P3FilingApproved

History / paused

Financial position

Cash and cash equivalents

Source and basis

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

KZIA PR & News

PR & News

KZIA SEC archive